STAAR Surgical Addresses Broadwood Partners’ Flawed, Misleading, and Misinformed Claims

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today issued the following statement with respect to the flawed, misleading, and misinformed claims recently made by Broadwood Partners, L.P.: Broadwood’s recent presentation recycles flawed, misleading, and misinformed claims about the process and considerations leading up to STAAR’s agreement with Al